The Food and Drug Administration Wednesday authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.

The agency said this includes infusion pumps with remote monitoring or remote manual control features that can help promote safe physical distances to reduce health care providers’ COVID-19 exposure.

FDA also updated its guidance for pharmacy compounders’ use of personal protective equipment.

The guidance, released yesterday, clarifies that intended-sterile drugs can be compounded in segregated compounding areas that are not within cleanrooms, assuming specific beyond-use dates are utilized. The agency said it adopted this policy to help assure patients’ access to necessary medications while reducing the risks of compounding when standard PPE are not available.

Related News Articles

Headline
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food…
Headline
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament…
Headline
The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months…
Headline
The Food and Drug Administration will end 22 COVID-19-related policies when the public health emergency ends May 11 and allow 22 to continue for 180 days,…
Headline
Qualified family members of health care workers whose lives were lost to COVID-19 may apply through April 20 at 3 p.m. CT for a Brave of Heart Scholarship. The…
Headline
Dwayne Gordon, M.D., and Richard Pratley, M.D., share lessons learned from AdventHealth’s multidisciplinary approach to caring for patients who experience…